BMI<30 kg·m−2 | BMI 30–39 kg·m−2 | BMI≥40 kg·m−2 | |
Subjects n | 36 | 39 | 32 |
Age years | 69 (28–93) | 62 (29–85) | 50 (25–75) |
Male | 23 (64) | 21 (54) | 14 (44) |
Caucasian | 28 (78) | 32 (82) | 25 (78) |
BMI kg·m−2 | 27 (23–29) | 34 (30–39) | 46 (40–68) |
Active smoking | 3 (8) | 5 (13) | 4 (13) |
HFpEF | 9 (25) | 15 (38) | 28 (88) |
CAD | 4 (11) | 2 (5) | 4 (13) |
CKD>II | 1 (3) | 2 (5) | 2 (6) |
Atrial fibrillation | 3 (8) | 4 (10) | 3 (9) |
Diabetes | 6 (17) | 10 (26) | 9 (28) |
Hypertension | 14 (39) | 25 (64) | 23 (72) |
Splenectomy | 2 (6) | 2 (5) | 2 (6) |
Hypothyroidism | 5 (14) | 8 (21) | 32 (6) |
OSA# | 7 (19) | 11 (28) | 20 (63) |
Provoked | 14 (39) | 11 (28) | 9 (28) |
Post-operative | 6 (17) | 9 (23) | 6 (28) |
Active malignancy | 6 (17) | 1 (3) | 0 |
Prior VTE | 10 (28) | 7 (18) | 5 (16) |
Prior gastric bypass surgery (Rou-En-Y) | 1 (3) | 2 (5) | 2 (6) |
Data presented as mean (interquartile range) or n (%), unless otherwise indicated. BMI: body mass index; HFpEF: heart failure preserved ejection fraction; CAD: coronary artery disease; CKD: chronic kidney disease; OSA: obstructive sleep apnoea; VTE: venous thromboembolism. #: diagnosis made prior to presentation or after.